Enhanced Efficacy of Sandblasted, Large-Grit, Alkaline-Etched (SLA) Titanium Surfaces Combined with Plasma Treatment and Secretory Leukocyte Protease Inhibitor (SLPI) Coating in Promoting Osteoblast Activity and Reducing Bacterial Adhesion
Authors:
- Wannapat ChouyratchakarnWCWannapat Chouyratchakarn
- Nattikan ThongjuiNTNattikan Thongjui
- Chayanisa PhutiyothinCPChayanisa Phutiyothin
- Onnicha SrisoparOSOnnicha Srisopar
- Surasak TangkamonsriSTSurasak Tangkamonsri
- Chakrit WiboonsuntharangkoonCWChakrit Wiboonsuntharangkoon
- Pakorn Sang-NgamPSPakorn Sang-Ngam
- Norrapon VichiansanNVNorrapon Vichiansan
- Nithi AtthiNANithi Atthi
- Chayarop SupanchartCSChayarop Supanchart
- Sarawut KumphuneSKSarawut Kumphune
Open Access
- 7 September 2026
- journal article
- research article
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (9) , 455
Abstract
The clinical success rate of titanium (Ti) implants is significantly reduced in elderly patients and by implant-associated bacterial infections. Thus, Ti surfaces were modified using sandblasted large-grit alkaline etching (SLA), argon-nonthermal plasma treatment, and recombinant human secretory leukocyte protease inhibitor (rhSLPI) coating. This study evaluated surface characteristics, human fetal osteoblast (hFOB 1.19) activities, and antibacterial efficacy. The modified surfaces exhibited increased roughness and hydrophilicity compared to Ti. The SBPTi-rhSLPI enhanced 7-day protein retention on the surface. While Ti promoted higher cell proliferation, the modified groups demonstrated superior cell adhesion and mineralization. Specifically, SBPTi-rhSLPI showed the highest cytoplasmic spreading, adhesion-related gene expression (Itg1, Itg2, Itg5, and Itg1), and mineralization. Additionally, rhSLPI-coated groups effectively reduced the adhesion of both S. aureus and E. coli. In conclusion, combining SLA modification, argon plasma treatment, and rhSLPI coating provides enhanced effects. This combined approach significantly enhances osteoblast adhesion and mineralization while possessing antibacterial potential, which could be a promising strategy to improve implant success rates.
Keywords
Funding Information
- Chiang Mai University (R68IN0067)
- National Research Council of Thailand (NRCT: 214460)
- hD Degree Program in Biomedical Engineering, Biomedical Engineering Institute, Chiang Mai University
This publication has 38 references indexed in Scilit:
- Improvement of osseointegration efficacy of titanium implant through plasma surface treatmentBiomedical Engineering Letters, 2022
- Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancerCytokine & Growth Factor Reviews, 2021
- Osteoporosis and the Ageing Skeleton2019
- Multiform TiO2 nano-network enhances biological response to titanium surface for dental implant applicationsApplied Surface Science, 2019
- Modification of Titanium Implant and Titanium Dioxide for Bone Tissue Engineering2018
- Peri‐implantitisJournal of Periodontology, 2018
- Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense responseCytokine & Growth Factor Reviews, 2016
- Role of integrin subunits in mesenchymal stem cell differentiation and osteoblast maturation on graphitic carbon-coated microstructured surfacesBiomaterials, 2015
- Modulation of cell adhesion, proliferation and differentiation on materials designed for body implantsBiotechnology Advances, 2011
- The influence of surface energy on early adherent events of osteoblast on titanium substratesJournal of Biomedical Materials Research Part A, 2009